BPTH (Bio-Path Holdings) Total Assets: $0.68 Mil (As of Mar. 2026)


What is Bio-Path Holdings Total Assets?

Bio-Path Holdings BPTH -19.63% Total Assets is $0.68 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Bio-Path Holdings's Total Assets for the quarter that ended in Mar. 2026 was $0.68 Mil.

During the past 12 months, Bio-Path Holdings's average Total Assets Growth Rate was -75.50% per year. During the past 3 years, the average Total Assets Growth Rate was -1.00% per year. During the past 5 years, the average Total Assets Growth Rate was 2.80% per year. During the past 10 years, the average Total Assets Growth Rate was 5.30% per year.

During the past 13 years, Bio-Path Holdings's highest 3-Year average Total Assets Growth Rate was 464.00%. The lowest was -51.20%. And the median was -1.50%.

Total Assets is connected with ROA %. Bio-Path Holdings's annualized ROA % for the quarter that ended in Mar. 2026 was -158.01%. Total Assets is also linked to Revenue through Asset Turnover. Bio-Path Holdings's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Bio-Path Holdings  (OTCPK:BPTH) Total Assets Explanation

Total Assets is connected with ROA %.

Bio-Path Holdings's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-1.08/( (0.69+0.677)/ 2 )
=-1.08/0.6835
=-158.01 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Bio-Path Holdings's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (0.69+0.677)/ 2 )
=0/0.6835
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Bio-Path Holdings Total Assets Related Terms

Bio-Path Holdings Total Assets Historical Data

* Premium members only.

The historical data trend for Bio-Path Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Path Holdings Total Assets Chart

Bio-Path Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.48 26.57 15.97 3.22 3.88

Bio-Path Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.88 2.20 0.75 0.69 0.68

Bio-Path Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Bio-Path Holdings's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=0.154+3.729
=3.88

Bio-Path Holdings's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=-8.486+9.163
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.68 Mil mean?
Bio-Path Holdings (BPTH) has a Total Assets of $0.68 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Bio-Path Holdings and its competitors.
Is Bio-Path Holdings' Total Assets too high?
Bio-Path Holdings' current Total Assets is $0.68 Mil.
How does Bio-Path Holdings' Total Assets compare to ADAPY and ZVSA?
Bio-Path Holdings' Total Assets of $0.68 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Bio-Path Holdings and its competitors. Bio-Path Holdings's current Total Assets is $0.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Path Holdings stock overvalued right now?
Bio-Path Holdings (BPTH) has a current Total Assets of $0.68 Mil. The current Total Assets is $0.68 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Bio-Path Holdings (BPTH), the current Total Assets is $0.68 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Path Holdings Business Description

Address No. 2407, 625 Stanwix Street, Pittsburgh, PA, USA, 15222
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.